Navigation Links
Tamoxifen causes significant side effects in male breast cancer patients
Date:11/16/2011

HOUSTON About half of male breast cancer patients who take the drug tamoxifen to prevent their disease from returning report side effects such as weight gain and sexual dysfunction, which prompts more than 20 percent of them to discontinue treatment, according to researchers at The University of Texas MD Anderson Cancer Center.

The study, which is the largest to date of how the estrogen-blocking drug is tolerated in men with breast cancer, was published today in the journal Annals of Oncology.

"While tamoxifen is effective in treating breast cancer in men, little is known about its toxicity," said Sharon Giordano, M.D., associate professor of medicine in MD Anderson's Department of Breast Medical Oncology and senior author of the study. "This research will help doctors and patients better understand the side effects men experience. With this information, patients can make more informed decisions about treatment risks and benefits."

Few Empirical Studies of Rare Disease

Only about 2,000 men are diagnosed with breast cancer in the United States each year, but its incidence is increasing. Since the disease is so rare, little published evidence exists to guide treatment decisions, and most are based on what works in women. There is limited data about the toxicity of anti-hormonal treatments in men.

Male breast cancers are almost always hormone-receptor positive. Tamoxifen blocks the growth-promoting action of estrogen on cancer cells, and it usually is prescribed to men after surgery.

MD Anderson is one of the nation's most active centers for treatment of male breast cancer. As a fellow working with Giordano, lead author Naveen Pemmaraju, M.D., now an assistant professor in MD Anderson's Department of Leukemia, saw a number of these patients.

"I was struck by how rare the disease is and how little published literature there is about it," he said. "I noticed many of these men were stop
'/>"/>

Contact: Laura Sussman
lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Side Effects May Spur Men to Drop Tamoxifen for Breast Cancer
2. Male breast cancer patients stop taking tamoxifen early because of drug-related side effects
3. Tamoxifen resistance -- and how to defeat it
4. Femara May Beat Tamoxifen at Preventing Breast Cancers Return
5. Women Who Drink, Smoke Are Less Likely to Stick With Tamoxifen
6. Leukemia drug reverses tamoxifen-resistance in breast cancer cells
7. Tamoxifen Wards Off Breast Cancers Return for More Than a Decade
8. Marker identifies breast cancer patients likely to respond to tamoxifen
9. Fox Chase researchers find that fish oil boosts responses to breast cancer drug tamoxifen
10. Researchers find possible clues to tamoxifen resistance in breast cancer patients
11. Tamoxifen May Offer Long-Term Heart, Cancer Protection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... , ... For decades, researchers in the genetics field have theorized that the ... changing after development in the womb. Now, researchers from the Icahn School of Medicine ... life – a process which helps to switch genes on and off. This histone ...
(Date:7/1/2015)... York, NY (PRWEB) , ... July 01, 2015 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – today announced that they will welcome four new members to their ...
(Date:7/1/2015)... ORANGE, Calif. (PRWEB) , ... July 01, 2015 ... ... advanced orthodontic technology and services, today announced that its fifth annual Smile for ... has raised $80,000 for the non-profit organization. In addition to supporting S4L in ...
(Date:7/1/2015)... Japan (PRWEB) , ... July 01, 2015 , ... ... 2015 of a new extraction plant for Linablue®, Spirulina-derived natural blue food coloring. ... Nutritionals, LLC, the DIC Group’s U.S. Spirulina* production base, began in May 2014. ...
(Date:7/1/2015)... ... ... The Collaborative for Children and Families (CCF) announced that it received a ... to improve quality of care and save costs for the child welfare sector by ... in New York’s Medicaid system. Experts agree that children need thorough solutions to live ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3
... after markets close at 2:00 p.m. PT (5:00 p.m. ET) ... MASI ), the inventor of Pulse CO-Oximetry and Measure-Through Motion ... quarter and fiscal year 2008 financial results for the period ... March 3, 2009.A conference call to review the results will ...
... Its Roster, Fielding Five Teams to Spread Personal Messages ... 1 and Type 2 DiabetesBRIDGEWATER, N.J., Feb. 5 ... glargine [rDNA origin] injection) and rapid-acting insulin Apidra(R) (insulin ... sponsors of Team Type 1, a team of amateur ...
... Feb. 5 Palomar Medical Technologies, Inc. (Nasdaq: ... light-based systems for cosmetic treatments, today announced financial results ... 2008. Revenues for the quarter ended December 31, ... product revenues, $2.2 million were royalty revenues, $0.5 million ...
... TORONTO, Feb. 5 /PRNewswire-FirstCall/ - Transition Therapeutics Inc. ... TTHI ) today announced the completion of patient ... gastrin analogue, TT-223, in patients with type 2 ... dose-ranging study to evaluate the safety, tolerability and ...
... Health Records (EHRs) have been promoted by industry and ... controlling costs. However, actual adoption of EHRs has ... to implementation costs, security, privacy, and systems integration. ... adoption barriers pale in comparison to basic usability and ...
... and identity theft response leader Kroll Fraud Solutions will host webinars ... a team of Kroll data security experts. , ... ... theft response leader Kroll Fraud Solutions will host a ...
Cached Medicine News:Health News:Masimo to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 3, 2009 2Health News:Masimo to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 3, 2009 3Health News:Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R) 2Health News:Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R) 3Health News:Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R) 4Health News:Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R) 5Health News:Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R) 6Health News:Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R) 7Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 2Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 3Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 4Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 5Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 6Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 7Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 8Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 9Health News:Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008 10Health News:Transition Therapeutics Announces Completion of Patient Enrolment of Phase 2 Study of TT-223 in Type 2 Diabetes Patients 2Health News:How to Select an Electronic Health Record System That Healthcare Professionals Can Use 2Health News:Kroll Fraud Solutions To Host Free Webinar Series on Preparing for and Responding to a Healthcare Data Breach 2
(Date:7/1/2015)... DIEGO , July 1, 2015  Imprimis ... company focused on the development and commercialization of ... company will ring The Nasdaq stock market closing ... celebrating the growing success of its Go Dropless™ ... 3.6 million cataract procedures are performed annually in ...
(Date:7/1/2015)... Lupin , Strides ... MPP Sub-licensees to Fourteen Companies     ... expansion of its network of generic manufacturers to 14 companies ... antiretrovirals (ARVs). New companies Lupin and Strides Arcolab recently signed ... the MPP licensed from ViiV Healthcare two months after its ...
(Date:7/1/2015)... 2015  Celsion Corporation (NASDAQ: CLSN ), an ... H. Tardugno , Chairman, President and CEO, is scheduled ... on Wednesday, July 8, 2015, at 4:15 p.m. Eastern ... Hotel located at 119 W. 56th Street, ... copy of the presentation will be available in the ...
Breaking Medicine Technology:Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 2
... spinal procedures. The SpineAssist platform for enhancing ... solution that enables surgery to be performed ... currently answers a growing need for accurate ... pedicle screw insertion for spine fusion procedures. ...
ACRYSOF®, Posterior Chamber Intraocular Lenses are indicated for the replacement of the human lens to achieve visual correction of aphakia in patients sixty years and older. These lenses are i...
Single piece PMMA lens, AC depth: 4.7....
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia....
Medicine Products: